U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
116491116491Intensive Lipid Lowering Treatment in Non-ST-elevation Acute Coronary Syndrome (NSTE-ACS) PatientsRecruitingNo Results AvailableAcute Coronary SyndromeDrug: Atorvastatin|Drug: Atorvastatinhttps://ClinicalTrials.gov/show/NCT01040936
116492116492Comparison of Digital Electronic Stethoscope to Computed Tomography (CT) Angiography in Detection of Coronary Artery DiseaseCompletedNo Results AvailableCoronary Artery DiseaseDevice: CardioSond Cardiac Sonospectrographic Analyzerhttps://ClinicalTrials.gov/show/NCT01040923
116493116493Cannabis for Inflammatory Bowel DiseaseRecruitingNo Results AvailableCrohn's Disease|Ulcerative ColitisDrug: smoking of cannabis|Drug: smoking cigarettes with placebohttps://ClinicalTrials.gov/show/NCT01040910
116494116494Addressing Health Literacy and Numeracy to Prevent Childhood ObesityActive, not recruitingNo Results AvailableObesity PreventionBehavioral: Health Communication and Obesity Prevention|Behavioral: Injury Prevention Armhttps://ClinicalTrials.gov/show/NCT01040897
116495116495Safety And Accuracy Study Of The Actisightâ„¢ Needle Guidance System In Patients Undergoing CT-Guided ProceduresCompletedNo Results AvailableCancerOther: ActiSight Needle Guidance Systemhttps://ClinicalTrials.gov/show/NCT01040884
116496116496Study of the Combination of VELCADE, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-CCompletedHas ResultsDiffuse Large B-Cell LymphomaDrug: VELCADE|Drug: Rituximab|Drug: Cyclophosphamide|Drug: Doxorubicin|Drug: Prednisone|Drug: Vincristinehttps://ClinicalTrials.gov/show/NCT01040871
116497116497Cognitive Rehabilitation of Operations Iraqi Freedom and Enduring Freedom (OIF/OEF) Veterans With Cognitive DisorderCompletedHas ResultsCognition DisordersBehavioral: Cognitive Strategy Training|Other: Placebo comparison grouphttps://ClinicalTrials.gov/show/NCT01040858
116498116498A Pharmacokinetic Study of Colchicine With an Oral ContraceptiveCompletedHas ResultsPharmacokineticsDrug: Norethindrone/Ethinyl Estradiol|Drug: Colchicine|Drug: Placebo (for Colchicine)https://ClinicalTrials.gov/show/NCT01040845
116499116499EMD 1201081 in Combination With Cetuximab in Second-Line Cetuximab-Naïve Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedHas ResultsSquamous Cell Carcinoma of the Head and Neck CancerDrug: Cetuximab|Drug: EMD 1201081https://ClinicalTrials.gov/show/NCT01040832
116500116500Does Pioglitazone Increase the Production of Prostacyclin (PGI2) and/or 15-EPI-Lipoxin A4 in Humans With Diabetes Mellitus Type 2?CompletedNo Results AvailableType 2 Diabetes MellitusDrug: Pioglitazonehttps://ClinicalTrials.gov/show/NCT01040819
116501116501Peer Coaching for Low-Income Patients With Diabetes in Primary CareCompletedNo Results AvailableDiabetes Type 2Behavioral: Usual care|Behavioral: Health coachinghttps://ClinicalTrials.gov/show/NCT01040806
116502116502Effect of Treatment BI 1744 CL (5 and 10 mcg) Versus Placebo on Exercise Endurance Time During Constant Work Rate Cycle Ergometry IICompletedHas ResultsPulmonary Disease, Chronic ObstructiveDrug: Olodaterol (BI 1744)|Drug: Olodaterol (BI 1744)|Drug: Placebo|Drug: Olodaterol (BI1744)|Drug: Olodaterol (BI 1744) placebohttps://ClinicalTrials.gov/show/NCT01040793
116503116503Safety and Efficacy Study of Icotinb in Non-small Cell Lung Cancer (NSCLC) PatientsCompletedHas ResultsNon-small Cell Lung CancerDrug: Icotinib|Drug: Gefitinibhttps://ClinicalTrials.gov/show/NCT01040780
116504116504Comparison of Web- Versus Classroom-based Basic Ultrasound and Extended Focused Assessment With Sonography for Trauma (EFAST) Training in Two European HospitalsCompletedNo Results AvailableLearningOther: Didactic training in basic ultrasound and the EFASThttps://ClinicalTrials.gov/show/NCT01040767
116505116505A Functional Magnetic Resonance Imaging (fMRI) Study of Expectancy on Acupuncture Treatment Outcomes in Knee Osteoarthritis (OA)RecruitingNo Results AvailableOsteoarthritis, KneeOther: Acupuncturehttps://ClinicalTrials.gov/show/NCT01040754
116506116506Observational Safety Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived VaccineCompletedNo Results AvailablePandemic Influenza A (H1N1)|A New Flu Virus of Swine OriginOther: Non-intervention observational studyhttps://ClinicalTrials.gov/show/NCT01040741
116507116507A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary DiseaseCompletedHas ResultsPulmonary Disease, Chronic ObstructiveDrug: Olodaterol (BI1744) Low|Drug: Olodaterol (BI1744) High|Drug: Tiotropium 18 mcg|Drug: Placebo (for Olodaterol (BI1744)l)|Drug: Placebo (for Tiotropium)https://ClinicalTrials.gov/show/NCT01040728
116508116508Immunogenicity and Safety of TNFa Kinoid in Rheumatoid Arthritis With Secondary Resistance to TNFa AntagonistsCompletedNo Results AvailableRheumatoid ArthritisBiological: TNFa Kinoid|Biological: TNF kinoidhttps://ClinicalTrials.gov/show/NCT01040715
116509116509The Effect of Methylphenidate on Decision-making Ability of Attention Deficit Hyperactivity Disorder (ADHD) AdultsCompletedNo Results AvailableAttention Deficit Hyperactivity DisorderDrug: methylphenidate|Dietary Supplement: sweetener pillhttps://ClinicalTrials.gov/show/NCT01040702
116510116510Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary DiseaseCompletedHas ResultsPulmonary Disease, Chronic ObstructiveDrug: Olodaterol (BI1744) Low|Drug: Placebo (for olodaterol BI1744)|Drug: Placebo (for Tiotropium)|Drug: Olodaterol (BI1744) High|Drug: Tiotropium 18 mcghttps://ClinicalTrials.gov/show/NCT01040689
116511116511Automated Telephone Nutrition SupportCompletedNo Results AvailableDiabetes MellitusBehavioral: Automated Telephone Nutrition Supporthttps://ClinicalTrials.gov/show/NCT01040676
116512116512Isocaloric Dietary Interventions for Insulin Resistance and the Metabolic SyndromeCompletedNo Results AvailableObesityOther: Dietary interventionhttps://ClinicalTrials.gov/show/NCT01040663
116513116513Metabolic Features of Post-Myopathy Patients Associated With Statin TreatmentTerminatedNo Results AvailableMyopathy (Statin Associated)https://ClinicalTrials.gov/show/NCT01040650
116514116514A Multiple Dose Study of TD-1211 in Healthy Volunteers and Patients With Opioid-Induced ConstipationCompletedNo Results AvailableHealthy|Opioid-induced ConstipationDrug: TD-1211|Drug: TD-1211|Drug: TD-1211|Drug: TD-1211|Drug: TD-1211|Drug: TD-1211|Drug: TD-1211|Drug: TD-1211|Drug: TD-1211|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01040637
116515116515Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate CancerActive, not recruitingHas ResultsProstate CancerRadiation: 15% risk of + LN - https://ClinicalTrials.gov/show/NCT01040624
116516116516Effectiveness of Music TherapyActive, not recruitingNo Results AvailableTuberculosisBehavioral: Music therapyhttps://ClinicalTrials.gov/show/NCT01040611
116517116517Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease ModelCompletedNo Results AvailableEosinophilic EsophagitisBiological: Omalizumabhttps://ClinicalTrials.gov/show/NCT01040598
116518116518Cost Effectiveness Of Linezolid In Central AmericaWithdrawnNo Results AvailableVentilator Acquired PneumoniaDrug: Linezolidhttps://ClinicalTrials.gov/show/NCT01040585
116519116519Laparoscopic Revision Gastric Bypass for Weight RecidivismCompletedNo Results AvailableWeight Regain|Weight Recidivism|Obesity Recidivism|Clinically Severe Obesityhttps://ClinicalTrials.gov/show/NCT01040572
116520116520Chemoembolisation of Non Resectable, Non Metastatic Hepatocellular CarcinomasCompletedNo Results AvailableCarcinoma, HepatocellularDrug: idarubicinhttps://ClinicalTrials.gov/show/NCT01040559

* Görseller ve İçerik tekif hakkına sahip olabilir